Alpha 2.0
Login Register
» Authors » Alessandra Tozzi

Alessandra Tozzi

Explore the profile of Alessandra Tozzi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 63
Followers 0
Related Specialties
General Medicine
Oncology
Cell Biology
Top 10 Co-Authors
Andrea Ciavattini
Viola Heinzelmann-Schwarz
Muriel Disler
Francis Jacob
Ricardo Coelho
Matteo Serri
Giovanni Delli Carpini
Andre Fedier
Nicolo Clemente
Celine Montavon
Published In
J Minim Invasive Gynecol
Int J Oncol
Gynecol Oncol
Medicine (Baltimore)
Cell Death Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma
Knipprath-Meszaros A, Tozzi A, Butenschon A, Reina H, Schoetzau A, Montavon C, et al.
Gynecol Oncol . 2023 May; 174:182-189. PMID: 37210928
Introduction: In the management of uterine myomas, laparoscopic surgery with morcellation enables a minimal invasive procedure. Cases of unsuspected uterine sarcoma dissemination have been reported and led to regulative restrictions....
2.
Vibrational Spectroscopy in Urine Samples as a Medical Tool: Review and Overview on the Current State-of-the-Art
Vigo F, Tozzi A, Disler M, Gisi A, Kavvadias V, Kavvadias T
Diagnostics (Basel) . 2023 Jan; 13(1). PMID: 36611319
Although known since the first half of the twentieth century, the evolution of spectroscopic techniques has undergone a strong acceleration after the 2000s, driven by the successful development of new...
3.
Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer
Coelho R, Tozzi A, Disler M, Lombardo F, Fedier A, Nunez Lopez M, et al.
Cell Death Dis . 2022 Oct; 13(10):909. PMID: 36307400
PARP inhibitors (PARPi) have revolutionized the therapeutic landscape of epithelial ovarian cancer (EOC) treatment with outstanding benefits in regard to progression-free survival, especially in patients either carrying BRCA1/2 mutations or...
4.
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines
Fedier A, Maggi N, Tozzi A, Disler M, Coelho R, Jacob F, et al.
Int J Oncol . 2022 Jun; 61(1). PMID: 35642662
Poly (ADP‑ribose) polymerase (PARP)‑inhibitors (PARPi) such as olaparib and niraparib are currently used as a treatment option for ‑deficient tumors and also show efficacy in platinum‑sensitive tumors. However, resistance to...
5.
Unfolded protein response, a link between endometrioid ovarian carcinoma and endometriosis: A pilot study
Ciavattini A, Delli Carpini G, Serri M, Tozzi A, Leoni F, Di Loreto E, et al.
Oncol Lett . 2018 Sep; 16(4):5449-5454. PMID: 30250617
The aim of the present study was to analyze the expression profile of unfolded protein response (UPR) genes in endometrioid ovarian carcinoma and to evaluate its possible involvement in the...
6.
Hypovitaminosis D and "small burden" uterine fibroids: Opportunity for a vitamin D supplementation
Ciavattini A, Delli Carpini G, Serri M, Vignini A, Sabbatinelli J, Tozzi A, et al.
Medicine (Baltimore) . 2016 Dec; 95(52):e5698. PMID: 28033263
The aim of this study was to evaluate the effect of vitamin D supplementation in women with hypovitaminosis D and "small burden" uterine fibroids.This study focused on 208 women diagnosed...
7.
Laparoscopic Treatment of Sclerosing Stromal Tumor of the Ovary in a Woman With Gorlin-Goltz Syndrome: A Case Report and Review of the Literature
Grechi G, Clemente N, Tozzi A, Ciavattini A
J Minim Invasive Gynecol . 2015 Mar; 22(5):892-5. PMID: 25764974
Gorlin-Goltz syndrome is a rare hereditary multisystemic disease. Multiple basal cell carcinomas, odontogenic keratocysts, and skeletal abnormalities are the main clinical manifestations of the syndrome, but several organs can be...